{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Lorlatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lorlatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lorlatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "lorlatinib",
    "trial_2_text": "Lorlatinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Lorlatinib Supplement: 60 participants will take Lorlatinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Lorlatinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Lorlatinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.29518091678619385,
      "78": 0.2935955226421356,
      "189": 0.2804676294326782,
      "188": 0.25743091106414795,
      "123": 0.18791383504867554,
      "173": 0.1740991175174713,
      "9": 0.17206844687461853,
      "20": 0.15974926948547363,
      "67": 0.1463119089603424,
      "17": 0.14602483808994293,
      "37": 0.1449182778596878,
      "228": 0.14151090383529663,
      "64": 0.13977719843387604,
      "68": 0.1338615119457245,
      "21": 0.13124209642410278,
      "46": 0.12954263389110565,
      "77": 0.12679652869701385,
      "49": 0.12622053921222687,
      "177": 0.12319326400756836,
      "243": 0.11808463931083679,
      "200": 0.11534509807825089,
      "350": 0.11413531750440598,
      "193": 0.11104340851306915,
      "239": 0.1084003746509552,
      "261": 0.10607317835092545,
      "79": 0.10011284798383713,
      "14": 0.09994737803936005,
      "29": 0.09672564268112183,
      "101": 0.09424404799938202,
      "131": 0.09201470762491226,
      "2": 0.09196807444095612,
      "5": 0.09182558953762054,
      "341": 0.09134618192911148,
      "114": 0.08945489674806595,
      "191": 0.08828631043434143,
      "38": 0.0859171524643898,
      "422": 0.08285123854875565,
      "104": 0.08121181279420853,
      "151": 0.07997962832450867,
      "116": 0.07980268448591232,
      "126": 0.07948503643274307,
      "72": 0.0794624462723732,
      "396": 0.0785326287150383,
      "30": 0.07824235409498215,
      "204": 0.07607318460941315,
      "179": 0.0750938132405281,
      "85": 0.07390287518501282,
      "36": 0.07336325198411942,
      "186": 0.07168914377689362,
      "194": 0.0697951465845108,
      "86": 0.06978413462638855,
      "27": 0.06969743967056274,
      "97": 0.06934718042612076,
      "139": 0.06852763146162033,
      "28": 0.06795646995306015,
      "61": 0.06771201640367508,
      "35": 0.06729185581207275,
      "102": 0.06715839356184006,
      "82": 0.06609297543764114,
      "441": 0.06595148146152496,
      "454": 0.06483183801174164,
      "466": 0.0633150264620781,
      "355": 0.06329333782196045,
      "76": 0.06225379928946495,
      "147": 0.0604424886405468,
      "234": 0.06004391610622406,
      "69": 0.05895781144499779,
      "180": 0.058536700904369354,
      "18": 0.058108989149332047,
      "132": 0.05636073276400566,
      "130": 0.05597211420536041,
      "339": 0.05444728210568428,
      "136": 0.05286745727062225,
      "33": 0.051592931151390076,
      "286": 0.05148185417056084,
      "276": 0.05111213028430939,
      "297": 0.05097914859652519,
      "288": 0.05088605359196663,
      "747": 0.050639864057302475,
      "249": 0.050585515797138214,
      "269": 0.05011304095387459,
      "508": 0.04975399002432823,
      "382": 0.04920526593923569,
      "257": 0.049156926572322845,
      "221": 0.0476192869246006,
      "92": 0.0474340058863163,
      "211": 0.046560630202293396,
      "75": 0.04644167423248291,
      "282": 0.046059612184762955,
      "456": 0.04603177681565285,
      "4": 0.045390449464321136,
      "122": 0.04537823051214218,
      "356": 0.04478100687265396,
      "108": 0.043966200202703476,
      "253": 0.043954163789749146,
      "98": 0.04295680671930313,
      "218": 0.0429474376142025,
      "535": 0.04292254149913788,
      "371": 0.04201653227210045,
      "363": 0.04199627786874771
    },
    "trial_2_ae": {
      "87": 0.29518091678619385,
      "78": 0.2935955226421356,
      "189": 0.2804676294326782,
      "188": 0.25743091106414795,
      "123": 0.18791383504867554,
      "173": 0.1740991175174713,
      "9": 0.17206844687461853,
      "20": 0.15974926948547363,
      "67": 0.1463119089603424,
      "17": 0.14602483808994293,
      "37": 0.1449182778596878,
      "228": 0.14151090383529663,
      "64": 0.13977719843387604,
      "68": 0.1338615119457245,
      "21": 0.13124209642410278,
      "46": 0.12954263389110565,
      "77": 0.12679652869701385,
      "49": 0.12622053921222687,
      "177": 0.12319326400756836,
      "243": 0.11808463931083679,
      "200": 0.11534509807825089,
      "350": 0.11413531750440598,
      "193": 0.11104340851306915,
      "239": 0.1084003746509552,
      "261": 0.10607317835092545,
      "79": 0.10011284798383713,
      "14": 0.09994737803936005,
      "29": 0.09672564268112183,
      "101": 0.09424404799938202,
      "131": 0.09201470762491226,
      "2": 0.09196807444095612,
      "5": 0.09182558953762054,
      "341": 0.09134618192911148,
      "114": 0.08945489674806595,
      "191": 0.08828631043434143,
      "38": 0.0859171524643898,
      "422": 0.08285123854875565,
      "104": 0.08121181279420853,
      "151": 0.07997962832450867,
      "116": 0.07980268448591232,
      "126": 0.07948503643274307,
      "72": 0.0794624462723732,
      "396": 0.0785326287150383,
      "30": 0.07824235409498215,
      "204": 0.07607318460941315,
      "179": 0.0750938132405281,
      "85": 0.07390287518501282,
      "36": 0.07336325198411942,
      "186": 0.07168914377689362,
      "194": 0.0697951465845108,
      "86": 0.06978413462638855,
      "27": 0.06969743967056274,
      "97": 0.06934718042612076,
      "139": 0.06852763146162033,
      "28": 0.06795646995306015,
      "61": 0.06771201640367508,
      "35": 0.06729185581207275,
      "102": 0.06715839356184006,
      "82": 0.06609297543764114,
      "441": 0.06595148146152496,
      "454": 0.06483183801174164,
      "466": 0.0633150264620781,
      "355": 0.06329333782196045,
      "76": 0.06225379928946495,
      "147": 0.0604424886405468,
      "234": 0.06004391610622406,
      "69": 0.05895781144499779,
      "180": 0.058536700904369354,
      "18": 0.058108989149332047,
      "132": 0.05636073276400566,
      "130": 0.05597211420536041,
      "339": 0.05444728210568428,
      "136": 0.05286745727062225,
      "33": 0.051592931151390076,
      "286": 0.05148185417056084,
      "276": 0.05111213028430939,
      "297": 0.05097914859652519,
      "288": 0.05088605359196663,
      "747": 0.050639864057302475,
      "249": 0.050585515797138214,
      "269": 0.05011304095387459,
      "508": 0.04975399002432823,
      "382": 0.04920526593923569,
      "257": 0.049156926572322845,
      "221": 0.0476192869246006,
      "92": 0.0474340058863163,
      "211": 0.046560630202293396,
      "75": 0.04644167423248291,
      "282": 0.046059612184762955,
      "456": 0.04603177681565285,
      "4": 0.045390449464321136,
      "122": 0.04537823051214218,
      "356": 0.04478100687265396,
      "108": 0.043966200202703476,
      "253": 0.043954163789749146,
      "98": 0.04295680671930313,
      "218": 0.0429474376142025,
      "535": 0.04292254149913788,
      "371": 0.04201653227210045,
      "363": 0.04199627786874771
    }
  },
  "safety": {
    "trial_1_safety": 0.34119752049446106,
    "trial_2_safety": 0.34119752049446106
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4794993996620178
  }
}